Prognostic factors for mortality in critically ill patients with infections caused by carbapenem-resistant gram-negative pathogens treated with ceftazidime-avibactam: a multicenter retrospective study. [PDF]
BMC Infect DisŞahinoğlu MS +6 more
europepmc +1 more source
Pharmacokinetics/pharmacodynamics of ceftazidime-avibactam in critically ill adult patients receiving continuous renal replacement therapy. [PDF]
Antimicrob Agents ChemotherLi C +7 more
europepmc +1 more source
Comparison of outcomes of KPC-producing Enterobacterales bloodstream infections treated with ceftazidime-avibactam and other conventional antibiotics: retrospective single-center study. [PDF]
Microbiol SpectrKwon K +10 more
europepmc +1 more source
A genomics-informed mechanism-based pharmacokinetic/pharmacodynamic model of cefiderocol and ceftazidime/avibactam against carbapenem-resistant <i>Achromobacter xylosoxidans</i>. [PDF]
Antimicrob Agents ChemotherArun B +6 more
europepmc +1 more source
Evaluation of the In Vitro Synergistic Activity of Ceftazidime/Avibactam Against Stenotrophomonas maltophilia Strains in Planktonic and Biofilm Cell Cultures. [PDF]
Pharmaceuticals (Basel)Damar-Çelik D +5 more
europepmc +1 more source
Risk factors for <i>in vivo</i> emergence of ceftazidime-avibactam resistance in KPC-producing <i>Klebsiella pneumoniae</i> and the associated resistance mechanisms: a case-control study. [PDF]
Microbiol SpectrChuang C +8 more
europepmc +1 more source